Cello Group plc (AIM:CLL) – numbers look encouraging but tough to understand their offering
The pharmaceutical and consumer strategic marketing group announced decent final audited results for the year to 31 December 2014. It’s quite tough for an outsider to fully understand what this business does but the numbers look quite encouraging!
Cello is a partnership of professionals that delivers specialist solutions primarily to the pharmaceutical and health sectors, as well as other high margin client industries. The Group operate through two companies; Cello Health and Cello Signal. Cello delivers its services from office networks in the UK, USA, Singapore and Hong Kong, through a group of over 800 professionals. 2014 saw a strong financial and operational performance from the Group. For the year ending December 2014 revenue increased by 6.4% to £169.9m, profit before tax was up 9.9% to £9.4m and basic earnings per share up 12.3% to 8.14p. The full…